Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies.
Françoise MascartMaya HitesEmmanuelle WateletGil VerscheldenChristelle MeurisJean-Luc DoyenAnne Van PraetAudrey GodefroidEmmanuelle PetitMahavir SinghCamille LochtVéronique CorbièrePublished in: Journal of clinical medicine (2023)
These results highlight the potential value of this combined HBHA/ESAT-6 IGRA as a triage test for the differential diagnosis of ADP.